pdf1 Intermediary results in the trial of CDX’s product for early diagnosis of prostate cancer Post published:18/05/2016
pdf1 The agreement is contingent on the sale of full rights in T.G.R. to Dashan for about NIS 7 million Post published:08/03/2016
